All News

The new initiative is meant to help advance women and allied businesses in cannabis and hemp.

Check out our exciting 2025 International Women's Day coverage!

In honor of International Women’s Day on March 8, 2025, we are excited to share with you our themed round up of women’s research.

The Commission provided information on testing updates intended to increase product safety and transparency.

Researchers analyzed data from more than 1000 young adults, linking heavy lifetime and recent use to diminished brain activation in some areas.

ILGM and Leafly announce their Home Grow Tour that will visit cities throughout the US to help educate growers on cannabis cultivation.

Avecho and Sandoz have signed an exclusive license and development agreement to commercialize CBD for use with insomnia in Australia.

Here, we bring you our top four recent news articles covering research for cannabis and ALS and autism, updates from the NCIA, and testing license applications in Alabama.

A recent study showed that retail cannabis sales may play a role in reducing drinking seen with young adults.

This webinar covered how cannabis for this neurodegenerative disease could provide better symptom relief and improve quality of life better than conventional treatments.

The Alabama Medical Cannabis Commission made the announcement in its most recent meeting, intending to advance the state medical cannabis program.

VIST Labs and Paralab have formed a strategic partnership to help expand decontamination and packaging solution options in Europe.

Adam Rosenberg’s experience across the cannabis supply chain, investment, education, and more is expected to help unify businesses toward federal legalization advocacy.

With a $3.5 billion investment plan, the company aims to become a leader in onshore API manufacturing, building DEA- and FDA-compliant facilities.

A recent press release disclosed that the FDA has granted DeFloria with a Investigational New Drug application for their AJA001 multi-cannabinoid botanical drug that may provide a new treatment for autism spectrum disorder.

Here, we bring you our top three recent news articles covering cannabis and exercise, new developments in CBD-based therapies, and hemp legislation.

HYTN announces their new GMP Stability Program and the validation of their vape cartridges used in international markets.

The study results on CBtru by dsm-firmenich could help expand opportunities for oral-based CBD therapies.

The company removed the eligibility barrier for medical cannabis patients in Australia to access certain products.

Researchers found CBD improved muscle endurance, mitochondrial function, and oxidative capacity, and more, with effects eliminated by antibiotics.

Hemp Beverage Alliance disclosed recently their new Hemp Beverage Expo.

With a focus on consumer safety, Missouri lawmakers recently passed bills regulating hemp-derived THC products.

Here, we bring you our top five recent news articles covering announcements from the US Hemp Roundtable, the latest cannabis research studies, and additional editorial commentary on the prevalence of schizophrenia after cannabis legalization.

A recent press release announced a new development agreement between Neurotech and RH Pharma focused on cannabinoid therapies.

Created by researchers at the University of British Columbia, the Index of Cannabis Equivalence creates a standardized framework for lower doses of cannabis.

A recent study may show a potential connection between frequent cannabis use and cavities and tooth decay.

This recently published study examined the effects of personalized coaching on the use of medical cannabis for chronic pain.

Artemis Growth Partners announced the first Global Cannabis Regulatory Summit taking place in March 2025.